Neurohormonal mechanisms

PreclinicalBiologic

IInstitut National de la Santé Et de la Recherche Médicale, France

Neurohormonal mechanisms is one of 14 biologic programs targeting Apathy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ApathyActive, not recruiting

ApathyPreclinical

Active, not recruiting

Competition

Competitive Landscape

14 competitors in Apathy

#DrugCompanyPhaseTrials

Cialis

Eli Lilly

Approved

1 2

Azilect

Teva

Approved

1 3

Neupro

UCB

Approved

1 4

Dexedrine Spansule

Innovent Biologics (Suzhou) Co. Ltd.

Approved

1 5

Ulotaront

IIntra-Cellular Therapies, Inc.

Phase 3

1 6

Risperdal

WWim Janssens

Phase 3

1 7

Provigil

NNuvo Research GmbH

Phase 3

1 8

Ritalin

Novartis

Phase 2

3 9

Azilect

Lundbeck

Approved

1 10

Wellbutrin

GGlaxo Dba Glaxosmithkline

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Apathy1 trial

Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System

Completed·IInstitut National de la Santé Et de la Recherche Médicale, France·N/A·NCT03272230·66 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Neurohormonal mechanisms. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Neurohormonal mechanisms compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Neurohormonal mechanisms. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Institut National de la Santé Et de la Recherche Médicale, France company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: IInstitut National de la Santé Et de la Recherche Médicale, France

Neurohormonal mechanisms

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Apathy1 trial

References

Drug Info

Quick Facts

Related News